News | December 13, 2021
ICMR Dibrugarh designs kit to detect Omicron variant in two hours
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.
The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
_1_256_384.png)
Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
_256_384.jpg)
It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis
It recommends using the vaccine to prevent the spread of the disease
Subscribe To Our Newsletter & Stay Updated
